Expression of p53 and p21(WAF1/CIP1) proteins in gastric and esophageal cancers: Comparison with mutations of the p53 gene

Digestive Diseases and Sciences

Volumn 43, Issue 2, 1998, Pages 279-289

  Seta, Toshikatsu ^a   Imazeki, Fumio ^a   Yokosuka, Osamu ^a   Saisho, Hiromitsu ^a   Suzuki, Takao ^a   Koide, Yoshio ^a   Isono, Kaichi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Esophageal cancer; Gastric cancer; Immunostaining; p21(WAF1 CIP1) protein; p53 protein

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA; NUCLEOTIDE; PROTEIN P21; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR SUPPRESSOR GENE; ADENOCARCINOMA; COMPARATIVE STUDY; DNA SEQUENCE; ESOPHAGUS TUMOR; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; SQUAMOUS CELL CARCINOMA; STOMACH TUMOR;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; MALE; MIDDLE AGED; MUTATION; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031594598     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018889818855     Document Type: Article

References (36)

1. Kern SE, Kinzler KW, Bruskin A, Tarosz D, Friedman P, Privas C, Vogelstein B: Identification of p53 as a sequence-specific DNA binding protein. Science 252:1708-1711, 1991
2. Mercer WE, Shields MT, Amin M, Sauve GJ, Appella E, Romano JW, Ullrich SJ: Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 87:6166-6170, 1990
3. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Edward Mercer W, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825, 1993
4. 1 cyclin-dependent kinases. Cell 75:805-816, 1993
5. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849, 1993
6. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299, 1995
7. Finlay CA, Hinds PW, Levine AJ: The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083-1093, 1989
8. Eliayahu D, Raz A, Gruss P, Givol D, Oren M: Participation of p53 cellular tumor antigen in transformation of normal embryonic cells. Nature 312:646-649, 1984
9. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253:49-53, 1991
10. Hollstein MC, Peri L, Mandard AM, Welsh JA, Montesano R, Metcalf RA, Bak M, Harris CC: Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res 51:4102-4106, 1991
11. Bennett WP, Hollstein MC, He A, Zhu SM, Resau JH, Trump BF, Metcalf RA, Welsh JA, Midgley C, Lane DP, Harris CC: Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene 6:1779-1784, 1991
12. Wagata T, Shibagaki I, Imamura M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T, Ishizaki K: Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res 53:846-850, 1993
13. Furihata M, Ohtsuki Y, Ogoshi S, Takahashi A, Tamiya T, Ogata T: Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human esophageal cancer. Int J Cancer 54:226-230, 1993
14. Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R, Gabbert HE: p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 74:2218-2223, 1994
15. Tamura G, Kihana T, Nomura K, Terada M, Sugimura T, Hirohashi S: Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res 51:3056-3058, 1991
16. Imazeki F, Omata M, Nose H, Ohto M, Isono K: p53 gene mutations in gastric and esophageal cancers. Gastroenterology 103:892-896, 1992
17. Renault B, van den Broek M, Fodde R, Wijnen J, Pellegata NS, Amadori D, Khan PM, Ranzani GN: Base transitions are the most frequent genetic changes at p53 in gastric cancer. Cancer Res 53:2614-2617, 1993
18. Kakeji Y, Korenaga D, Tsujitani S, Baba H, Anai H, Maehara Y, Sugimachi K: Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. Br J Cancer 67:589-593, 1993
19. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S: p53 mutation in gastric cancer: A general model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 54:759-764, 1993
20. Joypaul BV, Hopwood D, Newman EL, Qureshi S, Grant A, Ogston SA, Lane DP, Cushieri A: The prognostic significance of the accumulation of p53 tumor-suppressor gene protein in gastric adenocarcinoma. Br J Cancer 69:943-946, 1994
21. Hong S-IL, Hong W-S, Jang J-J, Lee D-S, Cho N-S, Jung M-E, Kim H-B, Ha G-W, Park I-C, Cho D-S, Cee J-I: Alterations of p53 gene in primary gastric cancer tissues. Anticancer Res 14:1251-1256, 1994
22. Srinivasan R, Roth JA, Maxwell SA: Sequence-specific interaction of a conformational domain of p53 with DNA. Cancer Res 53:5361-5364, 1993
23. Hall PA, Lane DP: p53 in tumor pathology: Can we trust immunohistochemistry? - revisited. J Pathol 172:1-4, 1994
24. Beahrs OH, Henson DE, Hutter RVP, Myers MH: Manual for Staging of Cancer, 3rd ed. Philadelphia, JB Lippincott, 1988, pp 40-46
25. Midgley CA, Fisher CJ, Bartek J, Vojtesek B, Lane DP, Barnes DM: Analysis of p53 expression in human tumors: An antibody raised against human p53 expressed in E. coli. J Cell Sci 101:183-189, 1992
26. El-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Ress JL, Hari Hon SR, Kinzler KW, Vogelstein B: Topological control of p21 WAF1/ CIP1 expression in normal and neoplastic tissue. Cancer Res 55:2910-2919, 1995
27. Lloyd RV, Schmidt K, Blaivas L, McCoy JP, Wilson BS: A rapid immunostaining method utilizing preformed antibody-avidin-biotin-peroxidase complexes. Am J Clin Pathol 83:636-639, 1985
28. Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, Marshall CJ: Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 51:3497-3502, 1991
29. Soussi T, Caron de Fromentel C, Mechali M, May P, Kress M: Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53. Oncogene 1:71-78, 1987
30. Varley JM, Brammar WJ, Lane DP, Swallow JE, Dolan C, Walker RA: Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas. Oncogene 6:413-421, 1991
31. Yasui W, Akama Y, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, Tahara E: Expression of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: Relationship with p53 status and proliferative activity. J Pathol 180:122-128, 1996
32. Gomyo Y, Ikeda M, Osaki M, Tatebe S, Tsujitani S, Ikeguchi M, Kaibara N, Ito H: Expression of p21 (waf1/cip1, sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma. Cancer 79:2067-2072, 1997
33. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54:2496-2503, 1994
34. Akagi M, Yasui W, Akama Y, Yokozaki H, Tahara H, Haruna K, Kajiyama G, Tahara E: Inhibition of cell growth by transforming growth factor 1 is associated with p53-induction of p21 in gastric carcinoma. Jpn J Cancer Res 87:377-384, 1996
35. Matsushita K, Kobayashi S, Kato M, Itoh Y, Okuyama K, Sakiyama S, Isono K: Reduced messenger RNA expression level of p21CIP1 in human colorectal carcinoma tissues and its association with p53 gene mutation. Int J Cancer 69:259-264, 1996
36. Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B, Philip Koeffler H: Absence of WAF1 mutations in a variety of human malignancies. Blood 84:3781-3784, 1994